Achieve Life Sciences, Inc. Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price
Achieve Life Sciences, Inc. (ACHV) had Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price of $9.33 per share as of 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 · last filed 2026-03-24
- 2025-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $9.33.
- 2024-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $12.05.
- 2023-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $19.25.
- 2022-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $34.44.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2025-12-31 | $9.33 10-K · filed 2026-03-24 | |
| 2024-12-31 | $12.05 10-K · filed 2025-03-11 | |
| 2023-12-31 | $19.25 10-K · filed 2024-03-28 | |
| 2022-12-31 | $34.44 10-K · filed 2023-03-16 | |
| 2021-12-31 | $98.12 10-K · filed 2022-03-10 | |
| 2020-12-31 | $221.96 10-K · filed 2021-03-11 | |
| 2019-12-31 | $22.93 10-K · filed 2020-03-13 | |
| 2018-12-31 | $73.05 10-K · filed 2019-03-14 | |
| 2016-12-31 | $91.79 10-K · filed 2018-03-01 | $10.54 10-K · filed 2017-02-23 |
| 2015-12-31 | $11.93 10-K · filed 2016-03-09 | |
| 2014-12-31 | $11.12 10-K · filed 2015-03-26 | |
| 2013-12-31 | $10.95 10-K · filed 2014-03-11 | |
| 2012-12-31 | $9.62 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |